| For: | Javaeed A, Ghauri SK. Metastatic potential and prognostic significance of SOX2: A meta-analysis. World J Clin Oncol 2019; 10(6): 234-246 [PMID: 31367532 DOI: 10.5306/wjco.v10.i6.234] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v10/i6/234.htm |
| Number | Citing Articles |
| 1 |
Sayantanee Chaudhury, Swagatika Panda, Neeta Mohanty, Saurav Panda, Diksha Mohapatra, Ravishankar Nagaraja, Alkananda Sahoo, Divya Gopinath, Natalia Lewkowicz, Barbara Lapinska. Can Immunoexpression of Cancer Stem Cell Markers Prognosticate Tongue Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2023; 12(8) doi: 10.3390/jcm12082753
|
| 2 |
Mohammed Nadim Sardoiwala, Boddu Mrunalini, Devangi Ghosh, Mohd Ayoub, Surajit Karmakar, Subhasree Roy Choudhury. Antibody functionalized targeted siRNA nanodelivery epigenetically controls Slug-Vimentin cross-talk for neuroblastoma inhibition. Nanomedicine: Nanotechnology, Biology and Medicine 2026; 72 doi: 10.1016/j.nano.2025.102899
|
| 3 |
Xian-hui Zhang, Wei Wang, Ya-qi Wang, Lei Zhu, Lan Ma. The association of SOX2 with clinical features and prognosis in colorectal cancer: A meta-analysis. Pathology - Research and Practice 2020; 216(1) doi: 10.1016/j.prp.2019.152769
|
| 4 |
Ioana Cristina Rotar, Elena Bernad, Liviu Moraru, Viviana Ivan, Adrian Apostol, Sandor Ianos Bernad, Daniel Muresan, Melinda-Ildiko Mitranovici. Therapeutic and Prognostic Relevance of Cancer Stem Cell Populations in Endometrial Cancer: A Narrative Review. Diagnostics 2025; 15(15) doi: 10.3390/diagnostics15151872
|
| 5 |
Miriam Gross-Cohen, Yifat Yanku, Ofra Kessler, Uri Barash, Ilanit Boyango, Angel Cid-Arregui, Gera Neufeld, Neta Ilan, Israel Vlodavsky. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression. Matrix Biology 2021; 99 doi: 10.1016/j.matbio.2021.05.001
|
| 6 |
Adriana G. Quiroz-Reyes, Paulina Delgado-Gonzalez, Jose Francisco Islas, Juan Luis Delgado Gallegos, Javier Humberto Martínez Garza, Elsa N. Garza-Treviño. Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL. Pharmaceutics 2021; 13(7) doi: 10.3390/pharmaceutics13071062
|
| 7 |
Gang Zhao, Xiaozhen Wang, Limei Qu, Zhu Zhu, Jinghui Hong, Haiqin Hou, Zuonong Li, Jun Wang, Zheng Lv. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis. Breast Care 2021; 16(1) doi: 10.1159/000505806
|
| 8 |
Hitomi Yasukawa, Yoshinori Ikehata, Naotaka Nishiyama, Hiroshi Kitamura. SOX2‑positive upper tract urothelial carcinoma: Clinicopathological characteristics and therapeutic implications. Oncology Letters 2026; 32(1) doi: 10.3892/ol.2026.15629
|
| 9 |
Zahra Hosseini-khah, Mohammad Reza Babaei, Mohsen Tehrani, Magali Cucchiarini, Henning Madry, Abolghasem Ajami, Nasser Rakhshani, Alireza Rafiei, Behrooz Nikbin. SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Current Oncology 2021; 28(4) doi: 10.3390/curroncol28040264
|